The bio­phar­ma in­dus­try tipped the scales on can­cer re­search years ago. Where the fed­er­al gov­ern­ment once played a ma­jor role in de­ter­min­ing what was stud­ied...

A Cal­i­for­nia biotech with a chron­ic pain drug that's long been ap­proved in Italy, but not the US, is go­ing on­to the pub­lic mar­kets through...

🏭 Genen­tech’s new $750M fac­to­ry: Roche’s Genen­tech is in­vest­ing $750 mil­lionin a new drug de­liv­ery de­vice fa­cil­i­ty at its site in Hills­boro, OR, which...

Two Re­pub­li­can law­mak­ers are ask­ing the FDA to re­ject clin­i­cal da­ta from Chi­na un­less a tri­al site has been re­cent­ly au­dit­ed by the agency, and...